희귀질환 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2031년)

Persistence Market Research has recently released a comprehensive report on the global Rare Disease Treatment Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• Rare Disease Treatment Market Size (2024E): USD 206.5 Mn
• Projected Market Value (2031F): USD 442.5 Mn
• Global Market Growth Rate (CAGR 2024 to 2031): 11.5%

Rare Disease Treatment Market - Report Scope:

The Rare Disease Treatment market includes therapies and medicines designed to treat diseases that affect a small percentage of the population, known as orphan diseases. These treatments involve a wide array of medications, biologics, gene therapies, and specialized care regimens that address conditions such as hemophilia, cystic fibrosis, Duchenne muscular dystrophy, and rare cancers. The market is driven by advancements in biotechnology, increased government support, and growing patient awareness. With significant unmet needs in rare disease treatments, the market is expanding rapidly, attracting a surge of investment from pharmaceutical companies and biotech firms.

Market Growth Drivers:

Several key factors are driving the growth of the Rare Disease Treatment market, including advancements in gene therapies, biologics, and orphan drugs, which offer targeted treatments for rare diseases. Increasing government and regulatory body support for orphan drug development, including financial incentives, faster regulatory approvals, and exclusivity periods, has boosted market expansion. Moreover, growing awareness among healthcare providers and patients about rare diseases, coupled with the rise in personalized medicine, is fueling the demand for rare disease treatments. The increasing focus on precision medicine and cutting-edge technologies, including CRISPR and gene editing, is likely to further drive the market forward.

Market Restraints:

Despite its growth potential, the Rare Disease Treatment market faces several challenges, including high research and development costs, regulatory hurdles, and limited patient populations. The development of orphan drugs and treatments for rare diseases often involves significant financial investments and time, with no guarantee of return due to the small number of patients. Additionally, high treatment costs and limited insurance coverage for rare disease therapies pose barriers to widespread adoption. Moreover, logistical and distribution challenges related to the delivery of specialized treatments and drugs also limit market growth in certain regions.

Market Opportunities:

The Rare Disease Treatment market presents significant growth opportunities, particularly with the increasing prevalence of genetic and rare diseases, advancements in biotechnology, and rising awareness. The growing interest in gene therapies and personalized medicine offers substantial potential for innovation and market growth. Furthermore, the expansion of regulatory frameworks to support the development of orphan drugs, alongside rising investments from venture capital and public-private partnerships, is expected to propel the market forward. Strategic collaborations between biopharmaceutical companies, research institutions, and healthcare organizations are expected to lead to breakthroughs in rare disease treatments and the development of novel therapies.

Key Questions Answered in the Report:

• What are the primary factors driving the global growth of the Rare Disease Treatment market?
• Which therapeutic categories are leading the adoption of rare disease treatments across different regions?
• How are advancements in gene therapy and biologics shaping the future of rare disease treatments?
• Who are the key players in the Rare Disease Treatment market, and what strategies are they employing to maintain their market positions?
• What are the emerging trends and future prospects in the global Rare Disease Treatment market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Rare Disease Treatment market, including Novartis, Sanofi, and Vertex Pharmaceuticals, are focusing on innovation, strategic partnerships, and the expansion of their treatment portfolios to remain competitive. These companies are investing heavily in research and development to discover new therapies for rare diseases, including gene therapies and biologics. Collaborations with academic research institutions, healthcare providers, and government bodies are critical for accelerating drug development and overcoming regulatory challenges. Furthermore, focusing on expanding market access through patient assistance programs and improved healthcare infrastructure is key for sustaining growth in this sector.

Key Companies Profiled:

• Novartis
• Sanofi
• Vertex Pharmaceuticals
• Biogen Inc.
• Alexion Pharmaceuticals
• Amgen Inc.
• Regeneron Pharmaceuticals
• AbbVie
• Eli Lilly and Company
• Bluebird Bio
• Shire (now part of Takeda)
• Pfizer Inc.

Rare Disease Treatment Industry Research by Category:

By Disease Type:

• Genetic Disorders
• Rare Cancers
• Neurological Disorders
• Autoimmune Diseases
• Other Rare Diseases

By Treatment Type:

• Gene Therapy
• Biologics
• Small Molecule Drugs
• Cell Therapy
• Others

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Market Overview
• 1.2. Market Analysis

2. Market Introduction

• 2.1. Market Definition
• 2.2. Market Taxonomy

3. Market View Point

• 3.1. Macro-Economic
• 3.2. Global Rare Disease Treatment Market Opportunity
• 3.3. Key Regulations: North America
• 3.4. Value Chain - Rare Disease Treatment Market

4. North America Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 4.1. Introduction -North America Rare Disease Treatment Market
• 4.2. Rare Disease Treatment Market Dynamics
  • 4.2.1. Drivers
  • 4.2.2. Restraints
  • 4.2.3. Trends
• 4.3. North America Rare Disease Treatment Market Size (US$ Mn) Analysis 2019-2023 & Forecast 2024-2031
  • 4.3.1. North America Rare Disease Treatment Market & Y-o-Y Growth By Country, 2024-2031
  • 4.3.2. North America Rare Disease Treatment Market Value (US$ Mn), Y-o-Y Growth & Absolute $ Opportunity, By Country 2024-2031
• 4.4. North America Rare Disease Treatment Market Size (US$ Mn) Analysis-2019-2023 and Forecast 2024-2031,
  • 4.4.1. By Country
  • 4.4.2. By Therapeutic Area
  • 4.4.3. By Drug Type
  • 4.4.4. By Drug Class
  • 4.4.5. By Mode of Administration
  • 4.4.6. By Distribution Channel
• 4.5. North America Rare Disease Treatment Market Attractiveness Analysis, 2024-2031
  • 4.5.1. By Country
  • 4.5.2. By Therapeutic Area
  • 4.5.3. By Drug Type
  • 4.5.4. By Drug Class
  • 4.5.5. By Mode of Administration
  • 4.5.6. By Distribution Channel

5. Latin America Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 5.1. Introduction -Latin America Rare Disease Treatment Market
• 5.2. Rare Disease Treatment Market Dynamics -
  • 5.2.1. Drivers
  • 5.2.2. Restraints
  • 5.2.3. Trends
• 5.3. Latin America Rare Disease Treatment Market Size (US$ Mn) Analysis 2019-2023 & Forecast 2024-2031
  • 5.3.1. Latin America Rare Disease Treatment Market & Y-o-Y Growth By Country, 2024-2031
  • 5.3.2. Latin America Rare Disease Treatment Market Value (US$ Mn), Y-o-Y Growth & Absolute $ Opportunity, By Country 2024-2031
• 5.4. Latin America Rare Disease Treatment Market Size (US$ Mn) Analysis-2019-2023 and Forecast 2024-2031,
  • 5.4.1. By Country
  • 5.4.2. By Therapeutic Area
  • 5.4.3. By Drug Type
  • 5.4.4. By Drug Class
  • 5.4.5. By Mode of Administration
  • 5.4.6. By Distribution Channel
• 5.5. Latin America Rare Disease Treatment Market Attractiveness Analysis, 2024-2031
  • 5.5.1. By Country
  • 5.5.2. By Therapeutic Area
  • 5.5.3. By Drug Type
  • 5.5.4. By Drug Class
  • 5.5.5. By Mode of Administration
  • 5.5.6. By Distribution Channel

6. Europe Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 6.1. Introduction -Europe Rare Disease Treatment Market
• 6.2. Rare Disease Treatment Market Dynamics
  • 6.2.1. Drivers
  • 6.2.2. Restraints
  • 6.2.3. Trends
• 6.3. Europe Rare Disease Treatment Market Size (US$ Mn) Analysis 2019-2023 & Forecast 2024-2031
  • 6.3.1. Europe Rare Disease Treatment Market & Y-o-Y Growth By Country, 2024-2031
  • 6.3.2. Europe Rare Disease Treatment Market Value (US$ Mn), Y-o-Y Growth & Absolute $ Opportunity, By Country 2024-2031
• 6.4. Europe Rare Disease Treatment Market Size (US$ Mn) Analysis-2019-2023 and Forecast 2024-2031,
  • 6.4.1. By Country
  • 6.4.2. By Therapeutic Area
  • 6.4.3. By Drug Type
  • 6.4.4. By Drug Class
  • 6.4.5. By Mode of Administration
  • 6.4.6. By Distribution Channel
• 6.5. Europe Rare Disease Treatment Market Attractiveness Analysis, 2024-2031
  • 6.5.1. By Country
  • 6.5.2. By Therapeutic Area
  • 6.5.3. By Drug Type
  • 6.5.4. By Drug Class
  • 6.5.5. By Mode of Administration
  • 6.5.6. By Distribution Channel

7. APAC Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 7.1. Introduction -APAC Rare Disease Treatment Market
• 7.2. Rare Disease Treatment Market Dynamics
  • 7.2.1. Drivers
  • 7.2.2. Restraints
  • 7.2.3. Trends
• 7.3. APAC Rare Disease Treatment Market Size (US$ Mn) Analysis 2019-2023 & Forecast 2024-2031
  • 7.3.1. APAC Rare Disease Treatment Market & Y-o-Y Growth By Country, 2024-2031
  • 7.3.2. APAC Rare Disease Treatment Market Value (US$ Mn), Y-o-Y Growth & Absolute $ Opportunity, By Country 2024-2031
• 7.4. APAC Rare Disease Treatment Market Size (US$ Mn) Analysis-2019-2023 and Forecast 2024-2031,
  • 7.4.1. By Country
  • 7.4.2. By Therapeutic Area
  • 7.4.3. By Drug Type
  • 7.4.4. By Drug Class
  • 7.4.5. By Mode of Administration
  • 7.4.6. By Distribution Channel
• 7.5. APAC Rare Disease Treatment Market Attractiveness Analysis, 2024-2031
  • 7.5.1. By Country
  • 7.5.2. By Therapeutic Area
  • 7.5.3. By Drug Type
  • 7.5.4. By Drug Class
  • 7.5.5. By Mode of Administration
  • 7.5.6. By Distribution Channel

8. MEA Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 8.1. Introduction -MEA Rare Disease Treatment Market
• 8.2. Rare Disease Treatment Market Dynamics
  • 8.2.1. Drivers
  • 8.2.2. Restraints
  • 8.2.3. Trends
• 8.3. MEA Rare Disease Treatment Market Size (US$ Mn) Analysis 2019-2023 & Forecast 2024-2031
  • 8.3.1. MEA Rare Disease Treatment Market & Y-o-Y Growth By Country, 2024-2031
  • 8.3.2. MEA Rare Disease Treatment Market Value (US$ Mn), Y-o-Y Growth & Absolute $ Opportunity, By Country 2024-2031
• 8.4. MEA Rare Disease Treatment Market Size (US$ Mn) Analysis-2019-2023 and Forecast 2024-2031,
  • 8.4.1. By Country
  • 8.4.2. By Therapeutic Area
  • 8.4.3. By Drug Type
  • 8.4.4. By Drug Class
  • 8.4.5. By Mode of Administration
  • 8.4.6. By Distribution Channel
• 8.5. MEA Rare Disease Treatment Market Attractiveness Analysis, 2024-2031
  • 8.5.1. By Country
  • 8.5.2. By Therapeutic Area
  • 8.5.3. By Drug Type
  • 8.5.4. By Drug Class
  • 8.5.5. By Mode of Administration
  • 8.5.6. By Distribution Channel

9. Competition Landscape

• 9.1. Global Rare Disease Treatment Market Structure
• 9.2. Global Rare Disease Treatment Market - Company Share Analysis
• 9.3. Company Profiles
  • 9.3.1. Novartis AG
  • 9.3.2. Pfizer Inc.
  • 9.3.3. F. Hoffmann-La Roche Ltd.
  • 9.3.4. Celgene Corporation
  • 9.3.5. AbbVie Inc.
  • 9.3.6. Johnson & Johnson Services, Inc.
  • 9.3.7. Shire
  • 9.3.8. Alexion
  • 9.3.9. Novo Nordisk A/S
  • 9.3.10. Sanofi
  • 9.3.11. Bayer AG
  • 9.3.12. Amgen, Inc.
  • 9.3.13. Allergan plc.
  • 9.3.14. Eisai Co. Ltd.
  • 9.3.15. Bristol-Myers Squibb Company
  • 9.3.16. Merck & Co., Inc.
  • 9.3.17. Vertex Pharmaceuticals
  • 9.3.18. Baxter
  • 9.3.19. BioMarin
  • 9.3.20. Teva Pharmaceutical Industries Ltd.

10. Global Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Region

• 10.1. Global Rare Disease Treatment Market Share Analysis & Y-o-Y Growth By Country, 2024-2031
• 10.2. Global Rare Disease Treatment Market Size (US$ Mn) Forecast By Region, 2024-2031
• 10.3. Global Rare Disease Treatment Market Attractiveness Analysis By Region, 2024-2031

11. Global Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Therapeutic Area Macro-economic Factors

• 11.1. Global Rare Disease Treatment Market share Analysis & Y-o-Y Growth By Therapeutic Area , 2024-2031
• 11.2. Global Rare Disease Treatment Market Size (US$ Mn) Forecast By Therapeutic Area , 2024-2031
• 11.3. Global Rare Disease Treatment Market Attractiveness Analysis By Therapeutic Area , 2024-2031

12. Global Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Drug Type

• 12.1. Global Rare Disease Treatment Market Share Analysis & Y-o-Y Growth By Drug Type, 2024-2031
• 12.2. Global Rare Disease Treatment Market Size (US$ Mn) Forecast By Drug Type, 2024-2031
• 12.3. Global Rare Disease Treatment Market Attractiveness Analysis By Drug Type, 2024-2031

13. Global Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Drug Class

• 13.1. Global Rare Disease Treatment Market Share Analysis & Y-o-Y Growth By Drug Class, 2024-2031
• 13.2. Global Rare Disease Treatment Market Size (US$ Mn) Forecast By Drug Class, 2024-2031
• 13.3. Global Rare Disease Treatment Market Attractiveness Analysis By Drug Class, 2024-2031

14. Global Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Mode of Administration

• 14.1. Global Rare Disease Treatment Market Share Analysis & Y-o-Y Growth By Mode of Administration , 2024-2031
• 14.2. Global Rare Disease Treatment Market Size (US$ Mn) Forecast By Mode of Administration , 2024-2031
• 14.3. Global Rare Disease Treatment Market Attractiveness Analysis By Mode of Administration , 2024-2031

15. Global Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Distribution Channel

• 15.1. Global Rare Disease Treatment Market BPS Analysis & Y-o-Y Growth By Distribution Channel, 2024-2031
• 15.2. Global Rare Disease Treatment Market Size (US$ Mn) Forecast By Distribution Channel, 2024-2031
• 15.3. Global Rare Disease Treatment Market Attractiveness Analysis By Distribution Channel, 2024-2031

16. Global Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031

• 16.1. Global Rare Disease Treatment Market Size (US$ Mn) Analysis-2019-2023 and Forecast 2024-2031,(US$ Mn)
• 16.2. Global Rare Disease Treatment Market size (US$ Mn) Analysis 2019-2023 and Forecast 2024-2031

17. Research Methodology